Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMP2 | P08253 | 6/20 | 1.00 |
| ▸ | MMP9 | P14780 | 6/20 | 1.00 |
| ▸ | MMP13 | P45452 | 4/20 | 0.70 |
| ▸ | MMP3 | P08254 | 3/20 | 0.70 |
| ▸ | MMP8 | P22894 | 2/20 | 0.70 |
| ▸ | CACNA1F | O60840 | 1/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.52 |
| ▸ | MAPT | P10636 | 1/20 | 0.52 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.52 |
| ▸ | HTR2A | P28223 | 1/20 | 0.52 |
| ▸ | HRH1 | P35367 | 1/20 | 0.52 |
| ▸ | SCN1A | P35498 | 1/20 | 0.52 |
| ▸ | SCN4A | P35499 | 1/20 | 0.52 |
| ▸ | BLM | P54132 | 1/20 | 0.52 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.52 |
| ▸ | CACNA1D | Q01668 | 1/20 | 0.52 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.52 |
| ▸ | CACNA1S | Q13698 | 1/20 | 0.52 |
| ▸ | CACNA1C | Q13936 | 1/20 | 0.52 |
| ▸ | SCN5A | Q14524 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4321603 | 0.83 | MMP2 (1.00) | MMP2MMP9MMP13MMP3MMP8 | |
| SCHEMBL18622047 | 0.78 | MMP2 (0.64) | MMP2MMP9MMP13MMP3MMP8 | |
| SCHEMBL713351 | 0.76 | MMP9 (0.61) | MMP2MMP9MMP13MMP3MMP8 | |
| SCHEMBL18197230 | 0.75 | LMNA (0.61) | MMP2MMP9MMP13MMP3MMP8 | |
| SCHEMBL4548022 | 0.75 | LMNA (0.61) | MMP2MMP9MMP13MMP3MMP8 | |
| SCHEMBL3195931 | 0.74 | MMP9 (0.59) | MMP2MMP9MMP13MMP3MMP8 | |
| SCHEMBL1861823 | 0.74 | MMP9 (0.59) | MMP2MMP9MMP13MMP3MMP8 | |
| SCHEMBL3207324 | 0.74 | MMP9 (0.59) | MMP2MMP9MMP13MMP3MMP8 | |
| SCHEMBL4384462 | 0.74 | ALDH1A1 (0.59) | MMP2MMP9CACNA1FALDH1A1MAPT | |
| SCHEMBL542865 | 0.74 | ALDH1A1 (0.59) | MMP2MMP9CACNA1FALDH1A1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 951 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12636254-B2 | Stabilization of phenobarbital sodium for injection | SUN PHARMA ADVANCED RESEARCH COMPANY LIMITED (IN) | 2026-05-26 | — | — | US | claimed |
| US-20240316049-A1 | STABILIZATION OF PHENOBARBITAL SODIUM FOR INJECTION | SUN PHARMA ADVANCED RESEARCH COMPANY LIMITED (IN) | 2024-09-26 | — | — | US | claimed |
| US-20240082161-A1 | STABILIZATION OF PHENOBARBITAL SODIUM FOR INJECTION | SUN PHARMA ADVANCED RESEARCH COMPANY LIMITED (IN) | 2024-03-14 | — | — | US | claimed |
| US-11857683-B2 | Stabilization of phenobarbital sodium for injection | SUN PHARMA ADVANCED RESEARCH COMPANY LIMITED (IN) | 2024-01-02 | — | — | US | claimed |
| WO-2023175542-A1 | STABILIZATION OF PHENOBARBITAL SODIUM FOR INJECTION | SUN PHARMA ADVANCED RESEARCH COMPANY LIMITED (IN) | 2023-09-21 | — | — | WO | claimed |
| US-20230031957-A1 | STABILIZATION OF PHENOBARBITAL SODIUM FOR INJECTION | SUN PHARMA ADVANCED RESEARCH COMPANY LIMITED (IN) | 2023-02-02 | — | — | US | claimed |
| WO-2023281441-A1 | STABILIZATION OF PHENOBARBITAL SODIUM FOR INJECTION | SUN PHARMA ADVANCED RESEARCH COMPANY LIMITED (IN) | 2023-01-12 | — | — | WO | claimed |
| CN-115583918-A | Preparation method of methyl phenobarbital | 精华制药集团南通有限公司 | 2023-01-10 | — | — | CN | claimed |
| WO-2021054927-A2 | GLUTATHIONE-CHOLESTEROL DERIVATIVES AS BRAIN TARGETING AGENTS | SOUTH DAKOTA BOARD OF REGENTS (US) | 2021-03-25 | — | — | WO | claimed |
| US-20200048305-A1 | GLUTATHIONE-CHOLESTEROL DERIVATIVES AS BRAIN TARGETING AGENTS | SOUTH DAKOTA BOARD OF REGENTS (US) | 2020-02-13 | — | — | US | claimed |
| EP-2560634-A1 | NITRIC OXIDE RELEASING PRODRUGS OF THERAPEUTIC AGENTS | Piramal Enterprises Limited (IN) | 2013-02-27 | — | — | EP | claimed |
| WO-2011132171-A1 | NITRIC OXIDE RELEASING PRODRUGS OF THERAPEUTIC AGENTS | PIRAMAL LIFE SCIENCES LIMITED (IN) | 2011-10-27 | — | — | WO | claimed |
| US-20110263526-A1 | Nitric Oxide Releasing Prodrugs of Therapeutic Agents | PIRAMAL LIFE SCIENCES LIMITED (IN) | 2011-10-27 | — | — | US | claimed |
| EP-2026788-A1 | THERAPEUTIC COMBINATION FOR PAINFUL MEDICAL CONDITIONS | SCHWARZ PHARMA AG (DE) | 2009-02-25 | — | — | EP | claimed |
| WO-2007141018-A1 | THERAPEUTIC COMBINATION FOR PAINFUL MEDICAL CONDITIONS | SCHWARZ PHARMA AG (DE) | 2007-12-13 | — | — | WO | claimed |
| US-20070043120-A1 | Therapeutic combination for painful medical conditions | UCB PHARMA GMBH (DE) | 2007-02-22 | — | — | US | claimed |
| US-20070042969-A1 | Combination therapy for pain in painful diabetic neuropathy | SRZ PROPERTIES, INC. (US) | 2007-02-22 | — | — | US | claimed |
| CN-1294519-A | Pharmaceutical composition containing a compound having an activity of promoting the absorption of an active ingredient | INPHARMA SA (CH) | 2001-05-09 | — | — | CN | claimed |
| EP-1073470-A1 | PHARMACEUTICAL COMPOSITIONS CONTAINING COMPOUNDS WITH ACTIVITY FOR THE ENHANCEMENT OF ABSORPTION OF ACTIVE INGREDIENTS | INPHARMA S.A. (CH) | 2001-02-07 | — | — | EP | claimed |
| WO-2000048636-A1 | PHARMACEUTICAL COMPOSITIONS CONTAINING COMPOUNDS WITH ACTIVITY FOR THE ENHANCEMENT OF ABSORPTION OF ACTIVE INGREDIENTS | INPHARMA S.A. (CH) | 2000-08-24 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (9 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240082161-A1 | STABILIZATION OF PHENOBARBITAL SODIUM FOR INJECTION | PYGB, EPM2A, CACNA1A | MMP2 1007/4885MMP9 2479/4885MMP13 1858/4885 |
| US-20070042969-A1 | Combination therapy for pain in painful diabetic neuropathy | GRIN2B, GRIN2A, GRIN3A | MMP2 854/4885MMP9 1201/4885MMP13 401/4885 |
| US-12636254-B2 | Stabilization of phenobarbital sodium for injection | SCN2B, CACNA1A, CYP3A5 | MMP2 1978/4885MMP9 1474/4885MMP13 1322/4885 |
| US-20230031957-A1 | STABILIZATION OF PHENOBARBITAL SODIUM FOR INJECTION | EPM2A, PYGB, ATP6V1B2 | MMP2 1175/4885MMP9 2497/4885MMP13 1819/4885 |
| US-20200048305-A1 | GLUTATHIONE-CHOLESTEROL DERIVATIVES AS BRAIN TARGETING AGENTS | GSTK1, GSTO1, GSTM2 | MMP2 1396/4885MMP9 1454/4885MMP13 2583/4885 |
| US-20110263526-A1 | Nitric Oxide Releasing Prodrugs of Therapeutic Agents | NOS2, NOS1, NOS3 | MMP2 1138/4885MMP9 1280/4885MMP13 2063/4885 |
| US-11857683-B2 | Stabilization of phenobarbital sodium for injection | EPM2A, PYGB, ATP6V1B2 | MMP2 1175/4885MMP9 2497/4885MMP13 1819/4885 |
| US-20240316049-A1 | STABILIZATION OF PHENOBARBITAL SODIUM FOR INJECTION | EPM2A, PYGB, ATP6V1B2 | MMP2 1169/4885MMP9 2633/4885MMP13 1901/4885 |
| US-20070043120-A1 | Therapeutic combination for painful medical conditions | PDE1B, CA2, CACNA1S | MMP2 467/4885MMP9 543/4885MMP13 169/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.